Just keep breathing is the motto today and always for those who have Cystic Fibrosis.

"We always say we will keep fighting until CF stands for 'cure found'," said Kyle Palumbo.

This event is raising funds for the Northeastern New York Chapter of Cystic Fibrosis Foundation in the hopes to further funding of resources and research for the rare disease.

"We're celebrating 36 years of the stair climb. What a wonderful event to watch. The first responders, all the firefighters, the police organizations and many individuals in the community that just want the honor of running 809 steps. But at the same time, they're raising funds to cure cystic fibrosis. It's just fantastic," said Karen Carpenter, chair of the Cystic Fibrosis Foundation Northeastern N.Y. Chapter.

It’s called the Annual CF Climb, a unique fitness test. Participants are climbing 42 flights in the tallest building in Albany, the Corning Tower. For many, this CF Climb is a test of endurance and timing, and also a great opportunity to learn more about this disease while gaining insight about how it feels.

"The wonderful thing about the climb and the challenging thing is that you get out of breath, you know how you're struggling to breathe. Your throat hurts, your lungs hurt, and that gives you a little bit of insight into what it might be like moment to moment with this with this disease. So, it's humbling," said Michelle Martinez, a participant.  

With over 100 climbers total, participants included first responders, adults and kids. The annual event raised $30,000.

For more information, visit cff.org.

Source link

Bradley Dryburgh thought his life was over before it had truly begun.

The 27-year-old, from Wollongong, has been living with cystic fibrosis (CF) all his life — having been diagnosed with the lung-damaging genetic illness at just three weeks old.

But in his late teens, his health took a terrifying turn.

Stream the world's best reality, entertainment and true-crime shows free on 7plus 7plus

“The first 18 years of my life were absolutely incredible,” Bradley tells 7Life.

“I was very healthy despite a diagnosis of liver disease at the age of nine and diabetes at 13 — both related to my CF.

“But at 18, I was challenged by my first real obstacle with cystic fibrosis when I began coughing up blood after a week of being unwell.

“Until this point, I had been told that if I was to ever cough up blood that I had to present to emergency immediately as there was a risk it could be fatal.”

Bradley Dryburgh shares the moment he ‘thought his life was over before it had truly begun.’ Credit: @bradleyjdryburgh

The shock experience left Bradley sitting down to compose his own eulogy at 26.

“Mum and dad, we did it. When I was born, the doctors told you that cystic fibrosis would ruin my life. Instead it became my super power,” Bradley said as he read out his emotional eulogy in a now-viral video.

“You both taught me the greatest lesson I could ever learn in life — that what you believe is what you become.

“Your belief not only saved my life, but it fuelled my purpose and gave my life meaning.

“I knew I belonged in the world... and for the rest of my life, I never felt anything less than that in your company.

“No parents should ever have to bury their child.

“So send me off into the breeze of the sea so that every time you look at the beauty of the world around you, you’re reminded that the boy who wasn’t meant to live past his early teens got the gift of 26 years on this beautiful earth.”

Bradley with his partner, Soph. Credit: Bradley Dryburgh

Now aged closer to 30, the inspiring Aussie has defied many odds.

Shortly after he was diagnosed with CF as a three-week-old baby, a doctor told his parents “he’d be better off with a terminal illness like cancer”.

The doctor posited that this was because cancer “would kill him or he would miraculously recover from it” — but that CF would “ruin his life”.

His shocked parents immediately found medical advice which gave “a more optimistic view on what his future could be”.

Despite also living with liver disease and diabetes, Bradley says it wasn’t until he began coughing up blood at 18 that he truly understood the seriousness of his CF.

Bradley explains the incredible impact running marathons has had on his life. Credit: @bradleyjdryburgh
Bradley says he was ‘a newbie runner’ when he started out. Credit: @bradleyjdryburgh

“That moment changed the meaning of my cystic fibrosis forever,” he says.

“It was the beginning of a six-year pattern in which every year I would find myself unwell again with another damaging lung infection.”

Then in July 2020, after Bradley experienced three days of consecutive bleed, he made a “life-changing choice”.

“I decided to run a marathon by the end of the year, to prove that cystic fibrosis doesn’t define me, or any of us, but how we chose to respond to it does,” he says.

“As a newbie runner at the time, I could barely run 5km.

“I set myself a challenge from my hospital bed and, four months later, ran 42.2km.

“Alongside Cystic Fibrosis Australia, we created the inaugural ‘#42forCf event’, despite many hurdles, including some more bleeds, in the lead up to the big day.”

Bradley was presented a Patron’s award for inspiration and advocacy for creating #42for CF. Credit: @bradleyjdryburgh
Bradley with a guest for his podcast, A Lot To Talk About. Credit: @bradleyjdryburgh

Bradley completed the marathon in four hours and 18 minutes, with 12 mates and “a large group of family, friends and community members who made helped make the day what it was”.

He says the event, which is no longer held, went on to be a three-part endeavour over a two-year period.

And it raised more than $120,000 for research, development and advocacy of life-saving drugs for CF patients.

“I’ve now run four marathons and a 50km ultramarathon,” he says.

“And while the event is no longer, I use my podcast ‘A Lot To Talk About’, and my work as a keynote speaker, to share the lessons that these moments of adversity have afforded me.”

Bradley describes those lessons as being “rooted in purpose, perspective and resilience”.

Daily life

For most of his life, Bradley has had to take 30-50 tablets per day.

He also has routine lung nebulisers and frequent physiotherapy sessions.

And he credits the life-changing cystic fibrosis drug Trikafta with a reduction of his symptoms.

“Touch wood, (I have had) no further bleeding of my lungs or challenges with infections as of yet,” he says.

Alcohol is off the table, with Bradley explaining he has never consumed it to ensure he is not damaging his liver any further.

But the main key to his relative good health is regular exercise.

“My daily exercise regime has been monumental in affording me the greatest health I have ever experienced at 27 years of age,” Bradley says.

Bradley plans to continue his podcast and helping others to live ‘fulfilling lives’. Credit: @bradleyjdryburgh

His training often encompasses “three gym sessions a week, two to four runs a week and sometimes an extra cardio session every week”.

He supplements workout sessions with ice baths and cold mornings in the ocean, plenty of animal proteins, healthy fats, carbs and the occasional indulgence of chocolate and almond croissants.

If there is one thing he wishes more people knew about chronic illnesses, it would be that “life can be incredibly challenging” for those living with debilitating conditions.

“(I wish) for people to not to take their health for granted and to treat it as a precious commodity,” he says.

“Good health is the foundation of everything we do in life.

“If you lose your health, you lose everything.”

‘Good health is the foundation of everything we do in life. If you lose your health, you lose everything.’ Credit: @bradleyjdryburgh

Bradley says he is currently the healthiest he’s ever been.

He continues to run and to set his sights on events, whether they be marathons, trails or “shorter, sharper races”.

Other plans are continuing his podcast — and starting a family with his partner, Soph.

“(I hope that) in the not-too-distant future (we can) have a couple of kids that keep us on our toes and remind us how blessed we are to have this incredible opportunity called life,” he says.

“Life is like a game of poker — you can’t pick the hand you are dealt but you can do your best to make the most of it.”

‘Super power’

His cystic fibrosis, he says, has always been “a blessing”.

“It has made me the man I am and has afforded me an opportunity to hopefully do some good and help others along the way,” he says.

Bradley — who runs his own podcast — advises others going through hardship that “you can be anything”.

“So why not be positive and use the power of perspective to see that on the other side of the hardships are great lessons and newfound strengths,” he says.

For more engaging lifestyle content, visit 7Life on Facebook.



Source link

Few pick up music for their physical health, and yet that's precisely the reason to play instruments like the clarinet, didgeridoo and trumpet, according to experts.

Playing a wind instrument regularly can complement the treatment of a lung disease, says Thomas Voshaar of Germany's Association of Pneumological Hospitals (VPK).

The reason is that the musician can only make a sound in a wind instrument when they build up enough pressure in their airways. And this is precisely what trains the respiratory muscles.

Various studies have also shown that children with asthma are able to improve their lung function by regularly playing wind instruments.

"Higher-pitched wind instruments such as the clarinet, oboe and trumpet are particularly suitable for this training," pulmonologist Thomas Voshaar says. Playing these instruments requires a particularly high amount of air pressure in the airways.

With lower brass instruments such as the tuba, on the other hand, a relatively low air pressure is sufficient when playing. The training effect on the lungs is therefore less pronounced.

One other wind instrument can also help with the metabolic disease cystic fibrosis: the harmonica. Those who play it breathe more intensively, which helps to clear the secretions in the airways of those affected.

The slight vibrations in the body that occur when making music also contribute to this. Pneumological experts say that playing the harmonica with cystic fibrosis can have similar effects to sports therapy.

There is also an instrument that can provide relief for anyone whose breathing briefly stops during sleep: the didgeridoo. Studies have shown that playing the didgeridoo regularly reduces sleep apnoea and that sufferers are more rested during the day.

"When learning to play the didgeridoo, a breathing technique is practised almost incidentally that is generally very important for patients with chronic lung diseases," says lung specialist Voshaar. This technique is characterised by the fact that the air is throttled when exhaling - which also strengthens the respiratory muscles.

Source link

The rays of dawn have seldom felt as invigorating as they did for Taylor Stephenson, a 26-year-old beacon of resilience, post her third double lung transplant at Duke Hospital. Born with cystic fibrosis, a genetic disorder merciless in its agenda, Taylor's life has been a testament to human spirit's indomitable will. Her journey, marked by its third milestone at Duke, is not just a medical marvel but a narration of hope, struggle, and the unyielding desire to live fully.

A Leap of Faith into Uncharted Waters

When Taylor received word that Duke Hospital's Lung Transplant Program, under the stewardship of Dr. John Reynolds, agreed to take on her case for a third double lung transplant, it was a mix of elation and apprehension. The procedure, rarified in its occurrence, with Duke performing 13 of the approximately 15 surgeries in the United States, was her beacon in a tempest. Her previous transplants, though initially successful, succumbed to rejection, leaving her gasping for not just air but for life itself. "Every breath was a battle," Taylor recounted, her eyes mirroring the resolve that has defined her 26 years. The prospect of a third transplant was her glimmer of hope, a testament to the advancements in medical science and the audacity of hope.

The Gift of Breath, The Gift of Life

Post-surgery, Taylor's transformation has been nothing short of miraculous. Freed from the confines of oxygen tanks and the constant struggle for air, she now dreams of climbing a mountain, an ambition that symbolizes not just a physical feat but a conquest over her own Everest-sized challenges. Her companion in these dreams, Millie, her loyal dog, epitomizes the everyday joys she once yearned for. "To breathe easily is a gift," she muses, a simple truth for many but a hard-fought victory for her. Her gratitude extends beyond the medical team to the donor's family, whose generosity has allowed her to envision a future ripe with possibility. Taylor's story, interwoven with the gift of organ donation, underscores the profound impact of giving, a gesture that transforms lives in the most fundamental way—allowing them to breathe, to live.

Charting a Course for the Future

Amidst her recovery, Taylor completed her associate's degree in psychology, a feat that speaks volumes of her determination. Gazing into the future, she contemplates a career in pharmacy, inspired by her journey, aiming to support others navigating the tumultuous waters of transplant or battling cystic fibrosis. "If my story can inspire even one person to keep fighting, to register as an organ donor, then every struggle has been worth it," she reflects. Her narrative is not just one of medical success; it's a beacon for those in the throes of despair, a reminder that the human spirit, supported by medical ingenuity and generosity, can overcome the insurmountable.

As Taylor Stephenson looks towards the horizon, her story unfurls a tapestry of human resilience, medical marvels, and the life-affirming power of organ donation. In the narrative of her life, each breath is a testimony to the triumph of will, the beauty of generosity, and the endless possibilities that life offers, one breath at a time.



Source link

Acute lung injury (ALI) is a condition which affects about 20 per cent of all patients in intensive care.Acute lung injury (ALI) is a condition which affects about 20 per cent of all patients in intensive care.

A new medicine hailed as a magic bullet could revolutionise the treatment of intensive care patients with lung disorders, scientists claimed.

The new drug – developed by researchers at Queen’s University, Belfast – could become the first effective treatment for acute lung injury (ALI) which claims the lives of thousands of people every year.

If successful the nanoparticle, which measures around one billionth of a metre, could also be used to treat other common lung disorders such as COPD and Cystic Fibrosis.

“Nanoparticles are perhaps one of the most exciting new approaches to drug development.

“Most research in the area focuses on how the delivery of drugs to the disease site can be improved in these minute carriers. Our own research in this area focuses on how nanoparticles interact with cells and how this can be exploited to produce therapeutic effects both in respiratory disease and cancer,” said Chris Scott from Queen’s school of pharmacy, who is leading the research.

Acute lung injury (ALI) is a condition which affects about 20 per cent of all patients in intensive care. Patients can become critically ill and develop problems with breathing when their lungs become inflamed and fill with fluid. They frequently require ventilators to aid breathing.

At present there are no effective treatments for acute lung injury because of the difficulty in reaching the inflammation.

The new nanoparticle from Queen’s has a surface which allows it to recognise and bind to immune cells called macrophages in the lungs – key to the uncontrolled inflammation that occurs in ALI. This binding induces a rapid reduction in the inflammation, and has the potential to prevent the damaging effects that will otherwise occur in the lungs of ALI patients.

Prof Scott said the new medicine would help save lives, money and would improve the quality of life of ALI survivors.

“There are patients who survive ALI but could have damaged lung architecture but, if you stop the condition from the onset the quality of life for survivors could be better.

“It is really exciting,” he added.

The project is developing the new nanomedicine towards clinical evaluation within the next three years, and is currently sponsored by a £505,000 grant for two years from the British Medical Research Council Developmental Pathway Funding Scheme.

 

Source link

Respiratory Care Device Market

Respiratory Care Device Market

Respiratory Care Device Market Is Experiencing Substantial Growth, Fueled by Increasing Prevalence of Respiratory Diseases & Advancements in Respiratory Care

AUSTIN, TEXAS, UNITED STATES, February 21, 2024 /EINPresswire.com/ -- The report provides a comprehensive analysis of the respiratory care device market, outlining its current size and anticipated growth. With an estimated value of USD 19.49 billion in 2022, Global Respiratory Care Device Market is poised to reach USD 38.55 billion by 2030, registering a projected compound annual growth rate (CAGR) of 8.9% during the forecast period from 2023 to 2030. This growth is attributed to several factors, including the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea, the growing geriatric population, and advancements in respiratory care technology. The report also delves into emerging trends such as the development of portable and wearable respiratory devices, the integration of telemedicine and remote monitoring capabilities in respiratory care, and the adoption of digital health solutions for personalized treatment and management of respiratory conditions. Additionally, it examines regional dynamics, competitive landscape, and regulatory considerations shaping the market. By offering insights into market size, growth projections, and key trends, the report aims to assist stakeholders in understanding and capitalizing on opportunities in the respiratory care device market.

Respiratory care devices play a crucial role in the management and treatment of various respiratory conditions by providing oxygen therapy, airway clearance therapy, mechanical ventilation, and monitoring of respiratory parameters. These devices help improve patient outcomes, enhance quality of life, and reduce the economic burden associated with respiratory diseases, leading to increased adoption by healthcare providers and patients worldwide.

Major Key Players in the Respiratory Care Device Market:

• Koninklijke Philips N.V. (Philips Healthcare)

• ResMed Inc.

• Medtronic plc

• Fisher & Paykel Healthcare Limited

• Becton, Dickinson and Company (BD)

• Chart Industries Inc.

• Drägerwerk AG & Co. KGaA

• Hamilton Medical AG

• Teleflex Incorporated

• 3M Company

Get Sample Report of Respiratory Care Device Market: www.snsinsider.com/sample-request/1072

Respiratory Care Device Market Growth Drivers

The respiratory care device market is being driven by several key growth drivers. Firstly, the increasing prevalence of respiratory diseases such as COPD, asthma, and pneumonia is creating a higher demand for these devices. Additionally, advancements in technology have led to the development of more innovative and effective respiratory care devices which are driving market growth. Moreover, the growing awareness about the importance of early diagnosis and treatment of respiratory illnesses among both healthcare professionals and patients has also contributed to the expansion of this market. Furthermore, the rapidly aging global population is expected to further boost the demand for respiratory care devices as elderly individuals are more susceptible to developing respiratory conditions. Overall, these factors combined are fueling the growth of the respiratory care device market and are projected to continue driving its expansion in the coming years.

Respiratory Care Device Market Opportunities

The respiratory care device market presents numerous opportunities for growth and innovation within the healthcare industry. With the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma, there is a growing demand for advanced respiratory care devices that provide efficient and personalized treatment options for patients. Technological advancements in the field have led to the development of portable and wearable devices that offer greater convenience and flexibility for both patients and healthcare providers. Additionally, the rise of telemedicine and remote patient monitoring has created new avenues for expanding access to respiratory care services, especially in rural or underserved areas. As the global population ages and environmental factors continue to impact respiratory health, there is significant potential for stakeholders in the market to collaborate on developing cutting-edge solutions that improve outcomes and enhance quality of life for individuals with respiratory conditions.

Respiratory Care Device Market Segmentation

By Product:

• Therapeutic Devices

• Monitoring Devices

• Diagnostic Devices

• Consumables and Accessories

By Indication:

• Chronic Obstructive Pulmonary Disease (COPD)

• Asthma

• Sleep Apnea

• Infectious Disease

• Others

By End-User

• Hospitals

• Home Care Settings

• Ambulatory Care Centers

• Others

The global market for respiratory devices is divided into therapeutic equipment, monitoring equipment, diagnostic equipment and consumables and accessories on the basis of product type. The therapeutic equipment industry accounted for the largest revenue share of the market in 2022. Increased prevalence of respiratory conditions such as chronic obstructive pulmonary disease, COPD, asthma, and sleep apnea, as well as the growing elderly population and rising pollution levels, are the main drivers of growth in this market. Examples of therapeutic devices include Nebulizers, Humidifiers, Oxygen Concentrators and Positive Airway Pressure Controllers.

The hospital sector was the largest revenue contributor to the respiratory equipment market in 2022. The three end user segments are hospitals, nursing homes and home health care facilities. The hospital sector dominated the market due to the significant demand for respiratory equipment for the treatment of respiratory diseases in severely ill patients in intensive care units and emergency departments. The need for respiratory care equipment in hospitals is being driven by the rising frequency of respiratory illnesses like chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis.

Make Enquiry About Respiratory Care Device Market Report: www.snsinsider.com/enquiry/1072

Key Regional Development

The North American market for respiratory equipment is the largest due to the high incidence of respiratory disorders and favourable reimbursement rules. Chronic obstructive pulmonary disease (COPD) is becoming more common in the US, which has a significant impact on the market's expansion. In order to improve the public's access to breathing equipment, which is expected to drive market growth, the United States government has also introduced a number of programmes.

The Asia Pacific region is expected to experience significant growth in the respiratory care devices market, due to increasing incidences of respiratory disorders and rising demand for home healthcare equipment. The expansion of the market in this area is expected to be driven by a large population and an increasing elderly population in countries such as China and India. Moreover, investments in healthcare infrastructure, which are expected to support market expansion, are increasing in the region.

Key Takeaway from Respiratory Care Device Market Study–

- Manufacturers are developing devices that not only treat respiratory conditions, but also contribute to early detection, monitoring, and management of these diseases. The growing awareness of the importance of proactive measures to manage respiratory disease in both healthcare providers and patients is driving this shift toward prevention.

- The trend towards integrating Digital Health technologies such as Remote Monitoring and Telemedicine to improve accessibility and patient involvement while cutting healthcare costs is increasing.

Recent Development Related to Respiratory Care Device Market –

- In 2021, Medtronic has entered into a Strategic Partnership with Tavish, an innovative technology company that focuses on improving the care for patients. New remote monitoring solutions for patients with chronic conditions, including respiratory disease, are to be developed and marketed by the partnership.

- In 2021, ResMed's two state of the art Continuous Positive Air Pressure CPAP devices, using artificial intelligence to perform an automatic adjustment of pressure levels in order to optimise patient comfort and treatment, have been introduced with their Air Sense 11 AutoSet and Air Sense 11 AutoSet.

Buy Respiratory Care Device Market Report: www.snsinsider.com/checkout/1072

Akash Anand
SNS Insider Pvt. Ltd
+1 415-230-0044
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram
YouTube



Source link

Cystic fibrosis (CF) is an autosomal recessive condition. This means that a person will have CF only if they receive the affected gene from both parents at conception.

Cystic fibrosis (CF) is a condition in which thick mucus causes damage to the lungs, the digestive system, and other organs throughout the body. CF is genetically inherited, which means it’s passed down through genes when sperm meets an egg.

Learn more about cystic fibrosis.

CF is a disease that is inherited in an autosomal recessive manner. The word “autosomal” means that the affected gene is located on a numbered chromosome. “Recessive” means that a person must inherit affected genes from both biological parents to develop the disease.

So, autosomal recessive cystic fibrosis can be more simply referred to as cystic fibrosis. In CF, the secretions that are meant to protect and lubricate the organs — such as mucus, sweat, and saliva — become thick. They may cause blockages in different areas of the body, inflammation, and even infections.

Again, a person must inherit one affected gene from each parent to develop CF. Someone who inherits just one affected gene is considered a carrier of CF and can pass the gene to any children they conceive.

CF is caused by mutations to the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Changes to the CFTR gene affect the proteins that regulate chloride and sodium (salt) exchange between cells.

When this gene is affected, the normally thin and slippery secretions in the body become thick. Thickened secretions may block tubes, ducts, and other passageways to the organs throughout the body.

CF primarily affects the lungs and airways, the gastrointestinal tract, and the pancreas. It may also affect the sweat glands and the genitourinary system, which includes the genitals and urinary tract.

Signs and symptoms of CF may appear soon after a baby is born. The thick mucus can build up in a baby’s lungs. It can also make sweat and digestive fluids thicker, causing issues in other parts of their body.

Respiratory signs and symptoms may include:

Other possible signs and symptoms include:

A doctor may diagnose CF by observing the signs and symptoms during a physical examination and taking a family history. In the United States, newborn screening for CF is typically performed with a simple heel prick within the first 3 days after birth.

To confirm the diagnosis, a doctor may suggest a sweat chloride test. During this procedure, doctors use a chemical combined with a weak electrical current to make the skin sweat. They then measure and analyze the sweat to look at its salt content. Saltier sweat may indicate that a person has CF.

Genetic (DNA) testing is another way to confirm a CF diagnosis. Doctors can use a blood test to look for CFTR mutations.

Treatment for CF can improve symptoms and quality of life, but it will not cure the disease. A person with CF may see several health professionals in different specialties (such as pulmonologists, dietitians, and respiratory therapists) to address symptoms of CF and the resulting complications.

Treatment includes:

Two drugs specifically used to treat CF are Pulmozyme (to thin and clear mucus) and Kalydeco (to help with the movement of chloride in the cells). Other drugs used for CF include Orkambi, Symdeko, and Trikafta.

Severe CF may cause significant damage to the lungs. In these cases, a lung transplant may help but is carried out on a case-by-case basis.

The main risk factor for developing CF is having a history of the disease on both sides of your biological family.

CF is more common among white people but can affect anyone.

Until recent years, a child with CF typically did not live beyond childhood. But as a result of early screening and improved treatments, a child who receives a CF diagnosis today may live into their thirties or forties or even longer.

What is an autosomal recessive disorder?

An autosomal recessive disorder is a condition that a person will develop only if they inherit affected genes from both parents during conception.

Does a lung transplant cure CF?

No. CF affects the way the cells transport chloride, causing thickened secretions that can damage the lungs. A lung transplant can address lung symptoms but cannot address the way the cells operate throughout the body.

What percentage of people carry the CF gene mutation?

According to the American Lung Association, about 30,000 people in the United States live with CF. Beyond that, around 1 in 30 people (3.3%) in the United States carry the gene for CF.

CF is an autosomal recessive condition inherited during conception. Doctors have made strides in the treatment of CF, and earlier detection and more advanced treatments have helped improve quality of life and extend life expectancy.

If you have a family history of CF and want to have biological children, talk with your doctor. You may want to consider genetic testing and genetic counseling to find out the chances that your child will have CF.

Source link

Singer and guitarist Dilbert Aguilar died of respiratory failure yesterday Severe pneumonia cases, For this reason, he was admitted to the intensive care unit (ICU). According to the Spanish Society of Internal Medicine (SEMI), pneumonia can be an extremely serious disease if not diagnosed promptly. Therefore, it is important to understand its symptoms and the signs that occur during respiratory failure.

According to experts at the Mayo Clinic, pneumonia is an infection that causes inflammation of one or both of the air sacs in the lungs. During this process, the air sacs fill with fluid or pus, causing coughing up phlegm, fever, chills, difficulty breathing, and respiratory failure. “Not all respiratory illnesses are pneumonia and require a chest X-ray to identify them,” emphasizes Dr. Javier Jauregui, a pulmonologist at the Ricardo Palma Clinic.

What are the symptoms of pneumonia?

Research from the Mayo Clinic shows: The signs and symptoms of pneumonia vary depending on several factors, such as age, the type of bacteria causing the infection, and the patient’s overall health. However, they point out mainly:

  • Chest pain when breathing or coughing
  • Disorientation or changes in mental perception (adults 65 years or older)
  • Coughing can produce phlegm
  • fatigue
  • Fever, sweats, chills, and shivering
  • Lower than normal body temperature (adults over 65 and people with weakened immune systems)
  • Nausea, vomiting, or diarrhea
  • Difficulty breathing
Cough is one of the most common symptoms of pneumonia.

It should be pointed out that Newborns do not show the same symptoms, Well, in addition to having a fever and cough, they may appear restless or tired. Additionally, they may have trouble breathing and eating.

In addition to symptoms, it is important to consider risk factors that may indicate a severe case of pneumonia. Among them, Mayo Clinic patients include patients over 65 years old, children under 2 years old, patients with undiagnosed health conditions, weakened immune systems and patients undergoing chemotherapy.

What does respiratory failure include?

In the words of Dr. Jauregui, Respiratory failure does not usually occur in anyone with pneumonia because risk factors must be present.

“Respiratory failure symptoms occur due to one of the following reasons: Various lung conditions and diseases, such as acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, Cystic fibrosis, pulmonary edema, pulmonary embolism, pulmonary fibrosis and pneumonia, said Dr. Ivan Romero Legro, a pulmonary specialist at the Cleveland Clinic.

Dr. Romero said other causes of respiratory failure include:
Heart or circulatory (blood flow) conditions and diseases. This includes heart attack, congenital heart disease, heart failure and shock.
A disease that affects the nerves and muscles that help you breathe. This includes muscular dystrophy, amyotrophic lateral sclerosis (ALS), severe scoliosis and Guillain-Barre syndrome.
Injury to the chest, spinal cord, or brain (including stroke).
Surgery requiring sedation or anesthesia.
Taking drugs or drinking too much alcohol.
Smoking or exposure to other lung irritants. This includes chemical fumes, dust, air pollution and asbestos.
Taking drugs or drinking too much alcohol.
age. Newborns (especially premature infants) and adults over 65 years of age are at higher risk of developing respiratory failure.

To identify it, Dr. Romero said, The most common symptoms are shortness of breath, shortness of breath (shortness of breath), extreme tiredness (fatigue), increased heart rate, and behavioral changes. From a physical perspective, this is also very common Cough with blood, excessive sweating, pale skin, headache, blue skin, lips, or nails.

“While many causes of acute respiratory failure are treatable, if left untreated, it can be fatal. As many as one-third of patients hospitalized with acute respiratory failure do not survive. “Chronic respiratory failure is often caused by an ongoing condition that worsens over time,” the Cleveland Clinic experts added.

therefore, Dr. Jauregui concluded by emphasizing the importance of correct treatment of respiratory diseases to avoid severe respiratory failure. Especially if the patient has other risk factors.

Source link

Introduction

Like vital air purifiers, our lungs inhale oxygen and remove carbon dioxide. But, when they can not expand to expel air outside your body, that medical condition is called pneumothorax or collapsed lungs. Join us in this blog to explore its types, causes, symptoms, diagnosis, treatment, and prevention.

What is a Pneumothorax?

Pneumothorax, commonly called collapsed lungs, occurs when air leaks into the space between your lungs (pleural space) and the chest wall. This air in the pleural space (fluid-filled space that covers the lungs) exerts pressure against your lungs, causing them to partially or completely collapse.

What are the Different Types of Pneumothorax?

There are two main types of pneumothorax: spontaneous and traumatic.

Spontaneous pneumothorax:

Primary spontaneous pneumothorax: This pneumothorax type happens when your lungs collapse for no apparent reason. It could be due to tiny air pockets in your lungs breaking apart. This is more likely to occur in people who smoke or if someone has a family history of pneumothorax.

Secondary spontaneous pneumothorax: This pneumothorax type can be caused by lung diseases such as pneumonia, asthma, lung cancer, etc. These conditions can lead to blockage in your lungs, creating bulging areas that may burst, causing a collapsed lung.

Traumatic pneumothorax:

Traumatic pneumothorax is caused due to injuries or medical procedures. These pneumothorax types include:

  • Injury-related pneumothorax: This type of collapsed lung results from chest injuries like fractures or wounds that puncture your lung.
  • Iatrogenic pneumothorax: When a medical procedure, such as a lung biopsy, accidentally punctures your lung, this can lead to a collapsed lung.

Other Types of Pneumothorax:

  • Tension pneumothorax: This is not a classification of the pneumothorax type but denotes the severity of the condition. It is more of a medical emergency. This severe form can occur when air gets in but cannot escape, causing pressure inside your chest, which can lead to a collapsed lung. You can experience this if you have a penetrating injury, a blow to the chest, and some medical procedures.
  • Catamenial Pneumothorax: This is a rare condition connected to endometriosis. In endometriosis, tissue growing outside the uterus can form a cyst. If this cyst bleeds into the pleural space, it can lead to a collapsed lung.

How Serious is a Pneumothorax?

A pneumothorax can range from mild to life-threatening, depending on the severity of a collapsed lung. In severe cases, especially tension pneumothorax, it can impact your breathing and heart and be considered a medical emergency requiring immediate attention.

What are the Symptoms of a Pneumothorax?

Signs and symptoms of pneumothorax include:

  • A sudden attack of chest pain is the very first and the main pneumothorax symptom.
  • Shortness of breath
  • Fast breathing
  • Chest tightness
  • Cough
  • Fatigue
  • Rapid heart rate
  • Anxiety
  • Bluish skin, lips, or nails

Make sure you consult your doctor immediately if you experience any of these pneumothorax symptoms.

What Causes a Pneumothorax?

There are three leading pneumothorax causes. These include:

Medical Conditions

Here are a few medical conditions that can lead to collapsed lungs:

  • Tuberculosis
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Idiopathic Pulmonary Fibrosis
  • Emphysema
  • Acute Respiratory Distress Syndrome (ARDS)
  • Pneumonia
  • Collagen Vascular Disease
  • Lung Cancer
  • Cystic Fibrosis

Injuries

A list of injuries that can lead to collapsed lungs are:

  • Car crash
  • Gunshot wounds
  • Stab wounds
  • A blunt and penetrating injury to the lungs.
  • During medical procedures that involve the insertion of a needle into the chest. For instance, lung biopsy, central venous line placements, and nerve blocks.

Lifestyle Factors

There are a few lifestyle factors to beware of, as they can lead to collapsed lungs:

  • Smoking
  • Drug usage
  • Engaging in activities such as diving, flying, or being at high altitudes where air pressure changes.

What are the Risk Factors for Pneumothorax?

The risk factors of pneumothorax are as follows:

  • Men are generally more prone to collapsed lungs than women.
  • The collapsed lungs caused by ruptured air blisters are more common in individuals aged 20 to 40, especially if they are very tall and underweight.
  • Other risk factors include having a family history of collapsed lungs, pregnancy, and endometriosis.
  • Ongoing assisted respiratory care and inflammation in the airways can also contribute to this medical condition.
  • Working in risky environments like construction sites, industrial settings, or jobs at heights (e.g., roofing, tree trimming, etc.) increases the chance of pneumothorax.

What are the Complications of a Pneumothorax?

Complications of a pneumothorax may include:

  • Air Leakage: Persistent air leakage may require additional medical interventions.
  • Infection: Open wounds or medical procedures can increase infection risk in the pleural space.
  • Tension Pneumothorax: Severe cases can lead to a medical emergency with chest pressure build-up.
  • Respiratory Distress: Significant collapse may cause breathing difficulties.
  • Cardiac Complications: Rare instances may impact heart function.
  • Recurring Episodes: Those with collapsed lungs may be at risk of repeat occurrences.

How is Pneumothorax Diagnosed?

Your doctor decides the method of pneumothorax diagnosis based on your condition. Your collapsed lung is diagnosed through imaging tests like chest X-rays or CT scans, allowing healthcare providers to visualise your collapsed lung and determine the extent of the condition.

How is Pneumothorax Treated?

Pneumothorax treatment varies based on its severity. It may include observation for minor cases, insertion of a chest tube to remove trapped air, or surgery for more severe collapses. The approach depends on the extent of the collapsed lung and individual health factors.

Can Pneumothorax be Prevented?

Yes, collapsed lungs can be prevented in the following ways:

  • Quit smoking to reduce the risk.
  • Stay alert for pneumothorax symptoms and seek prompt medical attention.
  • To prevent collapsed lungs, avoid chest injuries, especially during sports where impacts or collisions can pose a risk to the chest area. So, one should always play cautiously.
  • Practice safety measures in high-risk workplaces, such as wearing protective gear and following established protocols, to reduce the risk of collapsed lungs.

What Can I Expect if I Have a Pneumothorax?

If you have collapsed lungs, you may have to be in the hospital for a couple of days or longer under the supervision of your doctor for a complete and effective pneumothorax treatment.

How Long Does It Take a Collapsed Lung to Heal?

Your collapsed lungs can typically heal within a few days to two weeks.

Can You Fully Recover from a Pneumothorax?

Yes, full recovery from a punctured lung is possible. However, you do have a chance of recurrence. Therefore, you must follow the recommended pneumothorax treatment plan and follow-ups to ensure complete recovery.

Is Pneumothorax Life-Threatening?

In severe cases, pneumothorax can be life-threatening, especially if it leads to tension pneumothorax, a condition requiring immediate medical attention due to increased pressure within the chest.

How Do I Take Care of Myself?

You need to follow your doctor's advice, rest, avoid smoking, refrain from air travel during the recovery period, and avoid lifting heavy objects and strenuous exercise that might strain your lungs during this time.

When to See a Doctor?

You should see a doctor right away if you have sudden chest pain or trouble breathing, as these could be signs of pneumothorax. Early medical help is essential for effective pneumothorax treatment.

Conclusion

A collapsed lung is treatable, and if you notice pneumothorax symptoms, consult your doctor promptly for immediate care. Follow the preventive measures to avoid recurrence of this condition. Elevate your health with precision diagnostics from Metropolis Labs. Choose Metropolis for accurate and timely results for a proactive approach to your well-being. Explore more blogs on our website and take charge of your health for a healthier tomorrow.

Source link

In recent days, a wave of cough and cold has been sweeping across the country, affecting many individuals with severe to extremely severe symptoms. Dr Deepak Krishnamurthy, a Senior Interventional Cardiologist, shared his experience on Twitter, highlighting the severity of the cough and the need for nebulization, a treatment he had never needed before. Many others have also shared similar experiences, indicating a widespread issue.

Dr. Kuldeep Kumar Grover, Head of Critical Care & Pulmonology at CK Birla Hospital, Gurgaon, explains that the prevalence of severe coughing could be due to various reasons, including respiratory infections like the common cold, flu, or even COVID-19. Poor air quality due to pollution or allergens, as well as seasonal changes, can also exacerbate coughing.

ALSO READ: From Thyroid to PCOS, Here are the Detox Waters for Various Ailments!

The illness typically starts with a cough, runny nose, and sore throat, progressing to a severe form of cough within 1-2 days. Despite medication, the cough can persist for a week or even longer, with some individuals experiencing it for over a month. The intensity of the cough is so severe that it can make speaking difficult for some people. Additionally, the illness may begin like a typical flu with symptoms like sore throat and mild fever, but even after the fever subsides, the cough remains, often accompanied by severe body aches.

Cough and cold: Five best home remedies for a quick relief! | Tips News |  Zee News

To combat the illness, nebulization has been found to be effective. Nebulization delivers medication directly into the lungs through inhalation, providing targeted therapy for respiratory conditions such as asthma, COPD, and cystic fibrosis. It can relieve symptoms like coughing, wheezing, and shortness of breath, improving breathing function.

To stay safe, it's crucial to prioritize personal health and the safety of others. Key tips include covering your mouth and nose when coughing or sneezing, wearing a mask if you have a cough, practising good hand hygiene, avoiding close contact with sick individuals, and staying home if you're sick.

These Are The Best (and Worst) Face Masks For COVID-19, Per, 58% OFF

ALSO READ: Discover What is 'Suicide Disease' – Understanding Trigeminal Neuralgia in Detail and Urging Awareness!

Maintaining a healthy lifestyle with regular exercise, a balanced diet, and staying hydrated can also help strengthen the immune system and reduce the risk of respiratory infections. If experiencing severe or persistent coughing, it's important to consult a healthcare professional for proper diagnosis and treatment.

17 Health Benefits of Exercise That May Surprise You

In conclusion, with the prevalence of severe cough and cold symptoms, it's essential to take precautions and seek medical attention if necessary. By following these guidelines, individuals can protect themselves and others from the spread of illness.

 

 

ALSO READ: 

Experience a Blissful Plantation with THESE Gardening Tips for a Blooming Summer!

Spice Up Your Taste Buds: 5 Indian Cities Named in Best Food Cities in the World

Source link

Anita Kendrick, 54, from Welshpool who suffers from cystic fibrosis is raising money for a charity which tackles the condition by climbing the tallest peak in Wales every month for a year.

“When I was born in 1969 not much was known about Cystic Fibrosis only that most people born would not live past their teenage years,” said Anita. “I was told I would not live past 15 years old – I'm now 54.”

“I am walking in memory of Sally Watkins and Karen Duckers, both friends of mine, who both lost their lives way to early from Cystic Fibrosis.”

County Times: Anita climbing the sheer ice of SnowdonAnita climbing the sheer ice of Snowdon (Image: Anita Kendrick)

Cystic Fibrosis is a genetic condition which causes thick sticky mucus to block the digestive system and lungs, making breathing difficult, and making it easier to pick up lung infections.

Over time, repeated lung infections cause inflammation of the lungs, reducing life expectancy. This meant until very recently the average life expectancy of someone with the condition was around just 30 years old.

OTHER NEWS:

Anita is raising money for the Cystic Fibrosis Trust who fund “cutting-edge research, driving up standards of care and supporting people with the condition and their loved ones every step of the way.”

She is now around halfway through her challenge and has already faced severe heat in the summer and fierce cold in the winter which left parts of the mountain perilous – with streams of water frozen into solid blocks of ice.

County Times: Anita was joined by her 78 year old mother on the latest climbAnita was joined by her 78 year old mother on the latest climb (Image: Anita Kendrick)

Anita has already been joined by friends and family on her climbs, including her most recent ascent where she was joined by her 78-year-old mother.

“I have walked all the different routes up Snowdon now, apart from Crib Goch with its infamous knife edge, which I hope to do before July,” added Anita. “Many of my friends have accompanied me and the support and encouragement has been tremendous.

“I am determined to reach the summit of Snowdon every month to raise money. It will keep me fit and well and push me to my limit."

You can donate to Anita on her JustGiving page here



Source link

The cost of end-of-life hospitalizations for lung disease is high but varies widely, averaging $29,981 per patient; this raises the question of whether lung transplantation could avert acute care costs for some patients. These were among study findings published in Chest.

Researchers sought to estimate and characterize costs associated with end-of-life lung disease hospitalizations, using data from the Healthcare Cost and Utilization Project’s (HCUP) National Inpatient Sample (NIS) from 2009 to 2019. The investigators’ ultimate goal was to determine whether lung transplantation could be a more cost-effective treatment option for some of these patients. As the study authors stated, “To investigate the cost-effectiveness of lung transplant as a treatment option in pulmonary disease, we must understand costs attributable to end-of-life hospitalizations for end-stage lung disease.”

The study sample included NIS patients 18 to 74 years of age hospitalized for pulmonary disease. Patients with history of lung transplant were excluded. Pulmonary disease admissions, procedures, interventions, and complications were identified with ICD codes. Notably, the NIS database includes a 20% stratified sample of US hospitals that includes 1000 hospitals across 37 states.

Among the 2,671,071 pulmonary disease admissions identified, 109,924 (4.1%) resulted in in-hospital death. The investigators divided patients into 4 main disease groups: (1) obstructive lung disease (eg, chronic obstructive pulmonary disease [COPD]); (2) pulmonary vascular disease (eg, idiopathic pulmonary arterial hypertension [IPAH]; (3) cystic fibrosis (CF) and immunodeficiency disorders; and (4) restrictive lung disease (eg, idiopathic pulmonary fibrosis [IPF]).

Costs associated with lung transplantation are high, yet the procedure can potentially avert costly acute care delivered for individuals with end-stage lung disease.

Obstructive lung disease accounted for 94.1% of hospitalizations and 88.1% of in-hospital mortality; restrictive lung disease accounted for 4.7% of hospitalizations and 10.6% of in-hospital mortality.

Patients who died vs those discharged alive tended to be older (65 years vs 62 years), were more likely to be men (53.0% vs 45.2%), had a longer median length of stay (4.8 days vs 3.5 days) and were more likely to be admitted via hospital transfer (12.1% vs 3.8%).

The investigators estimated that the mean total inpatient cost of end-of-life lung disease hospitalizations was $1.42 billion per year, and that the mean inflation-adjusted hospitalization cost per patient was $29,981 (median: $18,043). The actual cost of hospitalizations varied widely by diagnosis and the procedures utilized. Younger patients receiving more procedures experienced the highest inpatient costs. Mechanical ventilation accounted for the greatest proportion of interventions among the most expensive admissions.

Nearly every year across the study period, mean inpatient cost increased for obstructive lung disease, and costs varied greatly for pulmonary vascular disease. The investigators found no significant trends in restrictive lung diseases or cystic fibrosis, although costs for CF were highly variable. Younger age, male sex, number of procedures and interventions, number of diagnoses at admission, and length of hospital stay were factors associated with increased cost.

Mortality rates for pulmonary vascular disease declined across the study period from 11.0% to 6.3%, although mortality rates for obstructive lung disease (3.8%), cystic fibrosis (1.6%), and restrictive lung disease (9.2%) remained stable over time.

Across the study period, significant increases were found in the use of dialysis, extracorporeal membrane oxygenation (ECMO), and mechanical ventilation. The investigators stated an increased rate of hospital transfers were associated with a proportionately greater increase in admissions resulting in in-hospital mortality.

Study limitations include unaccounted-for significant costs outside of hospitalization including rehabilitation, skilled nursing, and hospice, as well as in-hospital physician fees.

“Costs accrued during end-of-life hospitalizations vary across individuals but represent a significant healthcare cost,” said the investigators. “Costs associated with lung transplantation are high, yet the procedure can potentially avert costly acute care delivered for individuals with end-stage lung disease,” the study authors asserted, noting that lung transplant costs have yet to be included in cost-effectiveness studies.

Source link

A wave of cough and cold is spreading across the country, the classic characteristic of which is a severe to extremely severe cough.
Taking to Twitter his experience, Dr. Deepak Krishnamurthy wrote: This one cold cough virus wave in Bengaluru is very severe. I coughed so much in the night and had to take nebulizations at midnight, which I've never done before.Take care, people. My colleagues tell me that many have had acute bronchitis during the course of this virus. #Bengaluru not just #manflu Finally, I'm feeling much better today. The Senior Interventional Cardiologist's tweet has gained lots of attention. People have shared their experiences of dealing with the virus.
"I caught this terrible cough/virus on 4 February and haven't stopped coughing since. Endless nebulizers, antibiotics, a buffet of Strepsils/Vicks later — the cough still isn't gone and at times it is so severe that I feel I'll puke. Why aren't enough people talking about this?," writes one X user (formerly Twitter).

What is the illness?

"There could be several reasons why severe coughing is prevalent among many people these days. One primary cause could be respiratory infections, such as the common cold, flu, or even COVID-19. Poor air quality due to pollution or allergens can also exacerbate coughing. Additionally, seasonal changes can trigger respiratory issues for some individuals," says Dr. Kuldeep Kumar Grover, Head of critical care & Pulmonology - CK Birla Hospital, Gurgaon.
The illness starts with a cough, runny nose, and a sore throat. It progresses to a severe form of cough in 1-2 days. Even after taking medicine, the cough worsens and lingers for a whole week. In some cases, the cough lasts for over a month.

International Epilepsy Day: Debunking common myths around epilepsy

People have complained that the intensity of the cough is so severe that they find it even difficult to speak without coughing. The illness begins like a typical flu with classic symptoms like sore throat and mild fever; and even though the fever subsided, the cough lingers. This is accompanied by severe body aches.

How to stay safe?

Nebulization is helping people. Nebulization is a medical treatment that involves delivering medication directly into the lungs through inhalation. It works by converting liquid medication into a fine mist or aerosol that can be easily inhaled into the respiratory system using a nebulizer device. This method is particularly effective for treating respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Nebulization helps by delivering medication directly to the airways, where it can quickly and effectively relieve symptoms like coughing, wheezing, and shortness of breath. It provides targeted therapy to the lungs, making it a valuable tool in managing respiratory conditions and improving breathing function.
Apart from this, it's essential to prioritize both personal health and the safety of those around you. Here are some key tips to stay safe:
Cover your mouth and nose: Always cough or sneeze into a tissue or the inside of your elbow to prevent respiratory droplets from spreading. Dispose of tissues properly and wash your hands immediately afterward.
Wear a mask: If you have a cough, wearing a mask can help contain respiratory droplets and reduce the risk of spreading germs to others.
Practice good hand hygiene: Wash your hands frequently with soap and water for at least 20 seconds, especially after coughing, sneezing, or blowing your nose. If soap and water aren't available, use hand sanitizer with at least 60% alcohol.
Avoid close contact: Try to maintain a safe distance from others, especially if you're coughing frequently. This can help prevent the spread of illness.
Stay home if you're sick: If you have a cough or other symptoms of illness, it's important to stay home from work, school, or other activities to avoid spreading germs to others.
"To stay safe, it's essential to practice good hygiene habits like washing hands frequently, avoiding close contact with sick individuals, and wearing masks in crowded or enclosed spaces. Maintaining a healthy lifestyle with regular exercise, a balanced diet, and staying hydrated can also help strengthen the immune system and reduce the risk of respiratory infections. If experiencing severe or persistent coughing, it's crucial to consult a healthcare professional for proper diagnosis and treatment," Dr. Grover advises.



Source link

Vittorio Cecchi Gori is hospitalized in intensive care at the Gemelli Polyclinic in Rome due to respiratory failure. What is that? What is it due to? It is “a pathological condition caused by the inability of the respiratory system to guarantee adequate exchanges of oxygen between the environment and the blood”, with consequent “inability to obtain adequate blood values ​​of oxygen and carbon dioxide”.

Respiratory failure, what it is and causes

Respiratory failure “can be acute, when its onset is rapid and sudden, or chronic, when it occurs progressively to stabilize or evolve over time”. There are different causes at the origin, explains Laura Mancino, pulmonologist at the Angelo hospital in Mestre (Venice), in an in-depth analysis on the 'Let's take breath' portal, dedicated to breathing diseases.

“The most frequent causes of acute respiratory failure are acute pulmonary edema, massive pulmonary embolism, tension pneumothorax, asthmatic crisis, pneumonia causing acute respiratory distress syndrome such as Covid-19 related pneumonia”, i.e. associated with Sars-CoV-2 infection. Precisely due to pulmonary complications from Covid, Cecchi Gori had already been hospitalized at the beginning of 2022. The cause of acute respiratory failure can then be “traumas, intoxications from drugs or toxins”, lists the specialist. “The most common causes of chronic respiratory failure are” instead “chronic lung diseases such as chronic obstructive pulmonary disease (COPD) or interstitial lung diseases (pulmonary fibrosis), neurological diseases such as amyotrophic lateral sclerosis (ALS), obesity syndrome -hypoventilation (or Pickwick syndrome), cystic fibrosis, pulmonary hypertension, congenital or chronic worsening heart diseases”.

Symptoms

What are the symptoms? “Common manifestations of respiratory insufficiency are dyspnea, or shortness of breath – describes the pulmonologist – the reduction in oxygen saturation”, which is why Cecchi Gori arrived at Gemelli before having a respiratory crisis that left him led to hospitalization, or even “the use of the accessory muscles of ventilation, but also drowsiness to the point of coma”.

“Respiratory insufficiency can therefore” determine alterations in the values ​​of oxygen in the blood, but also of carbon dioxide. In the sense of a decrease or, what is much more serious, an increase. This distinction – specifies Mancino – is necessary to keep in mind” when it comes to deciding on treatment.

“When the partial pressure of oxygen in the blood falls below 55 mmHg – explains the expert – then it is necessary to treat respiratory failure”. We begin with the administration of oxygen through simple nasal cannulas, if the oxygen requirement is low, then moving on to special masks, up to high flow oxygen therapy through nasocannulae if the oxygen requirement is very high. “These measures are useful in correcting respiratory failure defined as hypoxemic and normocapnic, i.e. with normal carbon dioxide values”.

However, “some pathologies (the most common is COPD) are characterized not only by low oxygen values ​​but also by high carbon dioxide values” or hypercarbia. The accumulation of carbon dioxide in the blood “initially manifests itself with hyper-reactivity and agitation, and then leads to a reduction in the state of consciousness (the patient appears drowsy), up to coma”. In this case the administration of oxygen is not enough, the pulmonologist points out, in fact it must be controlled because “the excess would lead to a further increase in carbon dioxide. It will therefore be necessary to reduce the carbon dioxide values ​​using non-invasive ventilation devices (patient in sub-intensive or home therapy) and in the most serious cases invasive (patient intubated in intensive care or tracheotomised)”.

Read also

Source link

THE King’s cancer diagnosis serves to highlight the benefit of early detection.

Symptoms can alert you to changes in the body, but it’s important to take note of what is normal for you.

Dr Zoe Williams helps a reader with shortness of breath after having an angioplasty

4

Dr Zoe Williams helps a reader with shortness of breath after having an angioplasty
The King’s cancer diagnosis serves to highlight the benefit of early detection.

4

The King’s cancer diagnosis serves to highlight the benefit of early detection.Credit: Getty

What are your typical toilet habits? How much do you weigh? Do you know what your moles look like?

Knowing your “normal” is also helpful for spotting any clues when doing at-home health checks, which I urge all readers to do.

Once a month, women should check their breasts (and armpits and collarbone area) for changes, while men should check their testicles.

Always take up NHS invitations for mammograms, smear tests and abdominal aortic aneurysm screening.

And do your bowel cancer test when the kit comes through the letterbox – it could save your life.

If you’re aged between 40 and 74 and have no pre-existing conditions, you will be invited for an NHS Health Check every five years to assess your risk of serious health conditions.

Here’s what readers have been asking me this week . . . 

Q) I RECENTLY had an angioplasty as I had angina pain and a history of heart disease.

My arteries are now clear. However, I am still getting quite bad shortness of breath on lifting.

An endoscopy was clear and so was a chest X-ray. It’s not asthma either.

Diabetes symptoms and the signs of all types of diabetes

But I regularly get pain in the ­sternum. It feels like something pressing around my ribs.

 It has stopped me working, walking and doing anything physical. I’m 61 and diabetic. The symptoms started eight weeks ago.

A reader suffering from angina pain with a history of heart disease has contacted Dr Zoe with his concerns

4

A reader suffering from angina pain with a history of heart disease has contacted Dr Zoe with his concernsCredit: Getty

A) Your symptoms sound severe if you can’t work or walk, so definitely need to be looked into further.

Angioplasty is a procedure to open the inner tube of the arteries so oxygenated blood can flow properly to supply the heart muscle.

The heart pumps blood around the body without ever having a break, which is quite amazing really.

Unfortunately, it only takes one of those arteries to be significantly blocked to cause angina symptoms, which can cause pain and/or shortness of breath.

There are lots of heart conditions that can cause breathlessness and/or pain, including myocarditis, pericarditis, auto­immune conditions such as sarcoidosis and heart failure.

Anaemia, or other types of chronic disease, can also cause breathlessness.

I expect you are due to be followed up by the cardiology team, but I wouldn’t wait for your appointment.

You could contact your cardiologist’s secretary to see if the team think they should see you sooner.

Failing that, ask your GP to check you over and get some blood tests and an ECG in addition to the chest X-ray you already had.

Frozen shoulder’s got me screaming

Q) I’VE just been diagnosed with a frozen shoulder, but the pain is mainly in my bicep area, not so much in my shoulder. What causes it? Would a cortisone injection help? The pain is so bad I scream.

A) Adhesive capsulitis – or ­frozen shoulder – is a ­condition where the shoulder becomes painful and stiff, often for no particular reason.

It affects about three in 100 adults at some stage, but usually between ages 40 and 60 and is more common in women. People with diabetes are slightly more likely to get it.

The range of movement can significantly reduce, often so much that the shoulder can become completely “frozen”.

 It most often affects only one shoulder, but it can affect both. Without treatment, symptoms usually go away naturally but that can take up to three years.

The pain is often over the front of the shoulder, around the bicep, or down the outside of the arm, so this fits your symptoms.

Another cause of pain is biceps tendonitis, or an inflamed biceps tendon. It can happen in isolation or with a frozen shoulder so I would suggest an ultrasound to see exactly where the problem is.

The good news is that a ­steroid injection can treat both conditions, but it must go into the site where the problem is, so have an ultrasound first.

Meanwhile, try ice packs and anti-inflammatory medication. You can do rehabilitation exercises, but your GP or physio can advise on how often and when to start.

TIP OF THE WEEK

OMEGA-3 fatty acids are important for the functioning of your body, particularly your brain and eyes, and may be able to reduce the risk of heart disease, blood clots, dementia and death.

But your body can’t produce the amount of omega-3s you need to survive, therefore you need to eat it.

 Include salmon, sardines, mackerel, walnuts, flaxseeds and chia seeds in your weekly diet.

Q) IN the past six months I’ve lost a lot of weight, and I have painful joints, breathlessness and digestive problems.

I have bronchiectasis and one cystic fibrosis gene. I have been told I am a CF carrier. I went to my GP, who thought I might have diabetes, but my blood tests didn’t show anything.

However, I’ve never had a glucose diabetes test for people with the CF gene. Do you think I should ask the doctor for one?

Another reader is concerned about  painful joints, breathlessness and digestive problems

4

Another reader is concerned about painful joints, breathlessness and digestive problemsCredit: Getty

 A) Your case is fairly complex and it is important to get to the bottom of it, especially as your symptoms are progressively getting worse.

You’ve been diagnosed with bronchiectasis, which is a condition where the airways of the lungs become widened. This can lead to excess mucus in the lungs, leaving them more vulnerable to infection. It’s a condition that often affects people who have CF, but it can occur for other ­reasons too.

If you have bronchiectasis that is not well managed, you should be referred to a respiratory specialist doctor. It’s also important for your GP to examine you and do a full set of investigations looking for other causes of this rapid unintentional weight loss and your other symptoms.

These should include a full set of bloods and a chest X-ray as a minimum, and potentially other tests depending on your symptoms and examination findings.

For a diagnosis of cystic fibrosis, you need two mutated copies of a particular gene. If you have one normal copy and one mutated copy – as in your case – then you’re a carrier. You do not have CF, but could pass it to your children if their other biological parent is also a carrier. Most CF carriers don’t have symptoms, but some can have symptoms associated with CF.

New research suggests carriers have a higher risk for CF-related issues such as bronchiectasis. The 2020 study from the US compared 19,802 CF carriers to 99,010 people who had no mutations at all.

They assessed the risk of getting 59 health conditions. CF carriers were found to have a higher risk for 57 of the 59.

You and your GP need to be aware that you could be vulnerable to other conditions. It’s new research that will not be well known, so it may help to share the study with your GP and then discuss next steps.

One of the more likely conditions in a CF carrier is diabetes, so an oral glucose ­tolerance test may be a good idea.

Do let me know how you get on.



Source link

On rare, wonderful occasions, we have the good fortune of encountering irrefutably extraordinary individuals. These special someones possess a seemingly magical ability to motivate others. Sometimes they inspire creativity. Other times they sow the seeds of perseverance. In the best cases, they ignite joy. Islander Kellie Boston routinely performs all these feats with aplomb, and of late, she’s been “rocking this life” from a hospital room.

The quintessential renaissance woman, Kellie is dedicated to a plethora of passions – her family of seven (counting three Great Danes), her thriving photography business, the yoga workshops she leads, her entrepreneurial mentoring, her “rocking this life” apparel line and, oh yeah, the beach and the creatures who call it home. In late 2023, Kellie’s already chock-full reality took a sharp turn when Mike Boston, her beloved husband of 24 years, learned he was in dire need of a second double-lung transplant.

Mike, an easygoing, eternal optimist with a massive, sweet smile, was born with cystic fibrosis. He knew from a young age that his condition would be a challenge with which to contend. In 2018, his health began to decline, and he received his first double-lung transplant. After five and a half years of outstanding health, a bout with COVID-19 in late 2023 abruptly drove him back to the ICU. By early 2024, his survival would become dependent on a second double-lung transplant. Hoping for a miracle, the Bostons were utterly crushed when their long-time hospital declined to move forward with a second transplant.

Unwilling to abandon hope, and determined to protect Mike’s life by whatever means possible, Kellie began working the phones. After eight medical facilities rejected her pleas, Vanderbilt University Medical Center in Nashville stepped up to the plate. Miraculously, the Bostons would later discover that both Mike’s previous double-lung transplant in Jacksonville and his forthcoming transplant in Nashville were given the green light by the same individual. Dr. David Erasmus, medical director of the Vanderbilt Lung Institute Lung Transplant Program, threw them their vital lifeline twice.

Five days after being transported to Nashville via medevac, Mike received his transplants during a 10-hour surgery. Anyone who knows the Bostons knows they don’t live life in a typical fashion. Kellie aptly refers to herself as a “why not?” kind of person. She and her family are all about diving into situations with authenticity rather than running from fear. Likewise, the Bostons’ medical journey has also been undeniably out-of-the-ordinary.

Retransplantations are incredibly rare, but the Bostons have been-there-done-that against all odds. Breathing on one’s own, sans ventilator, 21 hours post-surgery is practically unheard of, however, Mike hit that milestone. An in-network hospital with an out-of-network life-saving surgery necessitates a mind-blowing sum, but the Bostons are determined to find a way to make it happen. Similarly, being in two places at once is a physical impossibility, but Kellie has come as close as imaginable.

An avid proponent of small business and the local community, Kellie supports fellow islanders on the regular, taking a great deal of pride in community involvement. The Bostons’ stint at the Jacksonville ICU happened to coincide with Kellie’s most bustling photography gig of the year, Dickens on Centre, in which she photographs a whopping 500 or so portrait sessions with Santa. Unbeknownst to Santa, his helpers and his young fans, Kellie’s nights during the event were spent sleeping in the ICU. She returned to the island to shoot, only to immediately rush back to Mike’s side in Jacksonville.

Although the Bostons are well-known and well-loved members of our community, they are typically rather private people. They kept Mike’s first double-lung transplant in 2018 under wraps for more than year, eventually confiding in only a small circle. It was during Dickens on Centre that Kellie realized extra support would be a necessity. As soon as word started to spread, the community that the Bostons have bolstered for the past 15 years jumped at the chance to rally around them. Before they knew it, a movement had formed, and the folks of Amelia Island were assembling to support Kellie and Mike.

To keep friends up to date on Mike’s condition, Kellie launched a Facebook page called “Breathing with the Bostons.” Suddenly, local businesses and individuals alike joined the cause, sponsoring a boatload of events on behalf of the Bostons. The Facebook page quickly became a source of encouragement for the family with well-wishing posts from near and far. In heart-warming fashion, close friends and colleagues, islanders they barely know and even very considerate strangers have all pitched in.

Today, just a few days post-transplant, Mike is exceeding all expectations and as Kellie proclaims, “He is killing it.” He has some arduous work ahead and will be in Nashville recovering for another 3-6 months. Kellie will, of course, be in tow, cheerleading for Mike and returning to the island every so often to grace her family and businesses with her one-of-a-kind magic.

The Bostons are the sort of folks who truly appreciate and savor all that life has to offer. They treasure our small-town community and are experiencing first-hand that “people really care for other people,” which has been a game-changer for them during such trying times. They are “extremely grateful, honored and humbled” by all the love that is being sent their way. Despite the daunting trials and tribulations they have faced, they believe wholeheartedly that positive attitudes will continue to pave their way. Among the many lessons the Bostons have taught us all by example, perhaps the most poignant is “do good and good things come back.” Here’s hoping that Kellie and Mike Boston will come back to Amelia Island soon, stronger than ever.   

For more information about the Boston’s journey and upcoming local events, visit www.facebook.com/breathingwiththebostons.

Source link

Respiratory Monitoring Devices Market is Anticipated to Grow

The global respiratory monitoring devices market has witnessed substantial growth, valuing at US$ 7.7 billion in 2021 and projected to exceed US$ 15 billion by 2031, marking a steady CAGR of 6.3%. The surge in demand for respiratory monitoring devices has been primarily fueled by the critical role they play in addressing respiratory ailments, particularly during the COVID-19 pandemic. These devices have become integral in healthcare facilities and homes, monitoring and managing respiratory conditions among patients.

The Role of Respiratory Monitoring Devices

Respiratory monitoring devices encompass an array of tools, from smart pulse oximeters to spirometers, aiding in the evaluation and management of various respiratory conditions like acute respiratory failure, chronic obstructive pulmonary disease (COPD), and asthma. Their importance extends across personal use, intensive care, and in-patient settings.

Request for a sample of this research report at (Use Corporate Mail Id for Quick Response) - www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1415&utm_source=OpenPR_Ganesh&utm_medium=OpenPR

Key Players and Innovations

The market's competitive landscape sees major players such as Medtronic, Philips Healthcare, Smiths Medical, and Masimo investing in product innovations and technological advancements. For instance, Medtronic expanded its remote respiratory monitoring solutions during the COVID-19 outbreak, while Masimo received FDA approval for its finger pulse oximeter, MightSat Rx, enhancing its share in the market.

Medtronic, Philips Healthcare (Koninklijke Philips N.V.), Smiths Medical (part of Smiths Group plc), Dragerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), and Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)

Drivers of Market Growth

The escalation in respiratory diseases like asthma, cystic fibrosis, and COPD, coupled with the prevalence of obstructive sleep apnea, has propelled the demand for respiratory monitoring devices. Around 65 million individuals globally struggle with COPD, while approximately 25 million contend with sleep apnea, emphasizing the critical need for advanced monitoring solutions.

Moreover, the rise in the elderly population, characterized by weakened immune systems and increased vulnerability to respiratory diseases, has significantly contributed to the market's growth. The geriatric demographic, expected to surge in both developed and developing countries, signifies a higher demand for therapeutic respiratory devices.

Product Segments and End-User Landscape

The market segments are diverse, ranging from pulse oximeters, capnographs, and spirometers to gas analyzers and polysomnographs (PSG). Among these, pulse oximeters lead the market with a dominant 37% share in 2021, attributing their success to technological advancements offering non-invasive and painless tests for oxygen saturation levels.

In terms of end-users, hospitals hold the largest share, around 39% in 2021, owing to the easy accessibility of respiratory devices, the growing patient population, and an increased demand for monitoring devices.

Regional Dynamics

North America spearheaded the market in 2021, securing a significant 36% share, driven by FDA approvals and established companies offering respiratory care devices. Meanwhile, Europe and Asia Pacific exhibited substantial shares in 2021, with Europe showing rapid growth due to intensified focus on respiratory care management in home care settings.

Buy this Premium Research Report | Immediate Delivery Available at - www.transparencymarketresearch.com/checkout.php?rep_id=1415&ltype=S&utm_source=OpenPR_Ganesh&utm_medium=OpenPR

The global respiratory monitoring devices market continues its growth trajectory, powered by the imperative need to manage and monitor respiratory conditions, especially in the wake of the COVID-19 pandemic. Technological advancements, increasing prevalence of respiratory diseases, and the rising elderly population globally underscore the criticality of these monitoring devices.

As key players continue to innovate and expand their product portfolios, the market is set for further expansion, with a focus on providing efficient, non-invasive, and accessible solutions for respiratory monitoring across diverse demographics and healthcare settings.

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Source link

Chronic Obstructive Pulmonary Disease (COPD) is a long-term lung condition that affects millions worldwide. It is characterized by breathlessness and predisposes to lung infections due to excessive mucus. Traditional treatments have often been ineffective due to the difficulty in delivering drugs past the thick mucus layer. However, a novel approach using inhalable nanoparticles filled with antibiotics could be the game-changer for treating COPD.

A Breakthrough in Drug Delivery

The recent development revolves around the creation of inhalable nanoparticles designed to release antibiotics deep inside the lungs. These nanoparticles are constructed from porous silica and filled with an antibiotic named ceftazidime. Encased within a shell of negatively charged compounds, the nanoparticles are effectively sealed, preventing antibiotic leakage. The negative charge also facilitates the nanoparticles’ penetration through mucus. Upon contact with the slightly acidic mucus in the lungs, the shell’s charge transforms from negative to positive, thereby releasing the medication.

Impact on COPD Treatment

The potential impact of this delivery system on COPD treatment is significant. Mice treated with these nanoparticles showed about 98 per cent less pathogenic bacteria inside their lungs than those given just the antibiotic. They also displayed fewer inflammatory molecules in their lungs and lower carbon dioxide levels in their blood, suggesting improved lung function. The findings suggest that these nanoparticles could enhance drug delivery in people with COPD or other lung conditions like cystic fibrosis, where thick mucus makes treatment challenging.

Beyond COPD: Potential Applications

While the breakthrough is promising for COPD treatment, the potential applications extend beyond this condition. For instance, natural plant compounds known as polyphenols have shown promise in treating thoracic cancers. High-dose radiotherapy is often required for these cancers, which can cause adverse effects in healthy tissues of the thorax. Polyphenols may help radiosensitize the tumor and protect normal tissues from radiotherapy-induced adverse effects.

Concerns and Future Directions

While the results are promising, some concerns remain. One of these is the clearance of these nanoparticles by the lungs. Further research is required to understand the long-term effects of these nanoparticles and their clearance mechanisms. Despite the concerns, the study represents a significant step forward in the treatment of lung conditions, particularly COPD. As research continues, it is hoped that these innovative treatments will soon be available to those suffering from these debilitating conditions.

Source link

A nebulizer machine is a compact mechanism that turns liquid medicine into a mist that can be easily inhaled by people with lung disease, asthma and more. You may use this excellent invention to treat cough as it is also a part of lung disease. If you are looking for something similar, then you are in the right place.

Read this article to learn about the best nebulizer machines in India which are readily available on Amazon, the most popular and trusted e-commerce website. All of the products mentioned in this article are handpicked and loved by their users ensuring a promising experience. You can go through these options, find the one that suits your needs the best and place your order with the help of the given buying links.

List of the Best Nebulizer Machine in India

Read more about other health care products in the heath and fitness section on the Top Trending Products page. Read about the Best Nebulizer Machine in India below.

1. Philips Home Nebulizer with SideStream Disposable Kit (White)


Check out one of the best options, Philips Home Nebulizer which comes with a SideStream disposable kit. It ensures a faster treatment time with consistent medication delivery in as little as 6 minutes. It also features SideStream technology which is a clinically proven technology that results in reliable and effective aerosol therapy. Since it is flexible for children and adults both, it becomes an economical choice resulting in a cost-effective aerosol therapy.

Special Features:

  • Fast Drug Output
  • Choice of Nebulizers
  • Proven SideStream Technology
  • Affordable High-Quality Aerosol Therapy
  • Economical Choice
Pros
Cons
Reliable and Easy to Use Minimal Technical Specifications
Compact Design Limited information
Clinically Proven SideStream Nebulizer

Buy Now: Philips Home Nebulizer with SideStream Disposable Kit (White)

2. Omron NE C28 Compressor Nebulizer For Child and Adult With Virtual Valve Technology


Omron NE C28 Compressor Nebulizer is designed for children and adults alike making it a versatile product. It comes with Virtual Valve Technology which ensures optimum medicine delivery to the respiratory system for both adults and children. It also features MMD which is expanded as a Mass Median Diameter that provides a particle size of approximately 5 micrometres ensuring effective medication delivery. This comprehensive kit also ensures to deliver medication at a rate of 0.4 millilitres per minute (without cap), optimising treatment efficiency.

Special Features:

  • Virtual Valve Technology
  • Usable for Both Adults and Children
  • MMD (Mass Median Diameter): 5 micrometres
  • Nebulizer Rate: 0.4 millilitres per minute
  • Comprehensive Kit: Includes compressor, nebulizer kit, air tubes, 5 replacement filters, mouthpiece, adult mask, child mask, instruction manual, and a carrying bag.
  • Power Consumption
  • Warranty
Pros
Cons
Efficient Medication Delivery No Detailed Technical Specifications
Comprehensive Kit Made in China
Compact Sporty Design

Buy Now: Omron NE C28 Compressor Nebulizer For Child and Adult With Virtual Valve Technology

3. Omron NEC 101 Compressor Nebulizer For Child & Adult


Check out the Omron NEC 101 Compressor Nebulizer which is designed for children and adults. It features a user-friendly operation which ensures fuss-free application releasing medication at the touch of a button. It is developed with the help of respiratory therapists which ensures a successful treatment of asthma, chronic bronchitis, allergies, and other respiratory disorders. This highly efficient nebulizer comes with a complete set of attachments which enhances its usability. Meeting the global standards, this product promises uncompromising quality.

Special Features:

  • User-Friendly Operation: The nebulizer is designed for a fuss-free application, administering medication at the touch of a button.
  • Developed with Respiratory Therapists: This product was developed in conjunction with respiratory therapists to ensure successful treatment of asthma, chronic bronchitis, allergies, and other respiratory disorders.
  • Particle Size of 3.9 Micron: The Omron NE-C101 offers efficient nebulization with a particle size of 3.9 micrometres, facilitating quick and reliable treatment.
  • Complete Set of Attachments: The nebulizer comes with a complete set of attachments, enhancing its usability.
  • Effective Nebulization: Breaks down medication into a median particle size, ideal for reaching lower airways, ensuring fast and effective treatment.
  • Long-Lasting Durability: Constructed with uncompromising quality that meets global standards, providing durability through extended periods of use.
Pros
Cons
Quick and Reliable Treatment Limited Component Information
Medical Device Standards
Global Quality Standards

Buy Now: Omron NEC 101 Compressor Nebulizer For Child & Adult

4. Dr Trust Junior Compressor Nebulizer Complete kit with Child and Adult mask


If you are looking for a nebulizer specifically for a child, then we suggest you check out the Dr Trust Junior Compressor Nebulizer Complete kit with Child and Adult mask. It comes in a cute penguin shape which ensures that it is inviting for the kids. It utilises Dr. Trust's proprietary "respiright" technology which results in effective atomisation of medication into fine particles which ensures faster and efficient treatment. The masks that come with this product are designed to help reduce aerosol deposition in and around the child's eyes which will ensure comfort for the kid.

Special Features:

  • Respiright Technology: Dr. Trust's proprietary "respiright" technology
  • Child-Friendly Design
  • Complete Kit with Masks
  • Aerosol Deposition Reduction
  • High-Quality Medical Grade Nebulizer
  • Contemporary Design and Comfort
Pros
Cons
Child-Friendly Design No Warranty Information
Complete Kit
Reduction in Aerosol Deposition

Buy Now: Dr Trust Junior Compressor Nebulizer Complete kit with Child and Adult mask

5. Omron Ultra Compact & Low Noise Compressor Nebuliser For Child & Adult


Next on the list is the Omron Ultra Compact & Low Noise Compressor Nebulizer For Child & Adult which features an ultra compact design making it convenient for use and storage. It also operates with low noise levels which will be a quieter and comfortable experience for the patient. It ensures to deliver the medication at an effective inhalation speed of 0.3ml/minute to ensure efficient and timely treatment.

Special Features:

  • 12 ml medication capacity
  • Aerosol Output Rate: 0.3ml/min
  • Ultra Compact Design
  • Low Noise Operation
  • Effective Inhalation Speed
  • Full Set of Accessories
Pros
Cons
User friendly No Warranty Information
Compact and Portable
Powerful Performance

Buy Now: Omron Ultra Compact & Low Noise Compressor Nebulizer For Child & Adult

6. Beurer Nebulizer, German Technology


Check out the Beurer Nebulizer which is made with German technology that emphasises on quality and precision in its design during manufacturing. It features compressed air technology which targets the upper and lower respiratory tracts during the treatment. It ensures speedy and efficient inhalation therapy for better results. It is designed to be easily disinfected so that it can incorporate hygiene and cleanliness in its usage.

Special Features:

  • German Technology
  • Compressed-Air Technology
  • 5 Years Warranty
  • Europe's No. 1 Brand
  • Short Inhalation Time
  • Extensive Accessories: Includes a nebulizer bottle, mouthpiece, adult mask, child mask, compressed air tube, and filter for comprehensive usage.
  • Storage Compartment for Accessories
  • Can be Disinfected
  • Nebulisation Performance: 0.4ml/min
Pros
Cons
Speedy Inhalation Therapy No Information on Noise Levels
High-Quality Manufacturing
5 Years Warranty

Buy Now: Beurer Nebulizer, German Technology

7. MEDTECH Handyneb Super Ultra Compact and Low Noise Compressor Nebuliser Machine


MEDTECH Handyneb Super Ultra Compact and Low Noise Compressor Nebulizer Machine is manufactured by the largest nebulizer manufacturer in India who has an experience of 20 years that brings expertise and reliability. This brand also prioritises safety and hence this product comes with built-in safety fuse that protects the motor from current fluctuations. This compact and portable nebulizer has a slim body and a handle which ensures that it is really easy to carry it around.

Special Features:

  • Largest Nebulizer Manufacturer in India
  • Innovative Integrated Baffle Design
  • Complete Nebulization Kit
  • Safety Fuse Included
  • Compact, Portable Design
Pros
Cons
Handy Design and Low Noise Operation No Information on Warranty
Medicine Bottle with Integrated Baffle
Added Safety Feature

Buy Now: MEDTECH Handyneb Super Ultra Compact and Low Noise Compressor Nebulizer Machine

8. OTICA Nebulizer Machine for Adult and Kids


Check out the OTICA Nebulizer Machine for Adult and Kids which targets all age groups making it an ideal choice for families with adults and kids. It comes with a complete mask set including adult and paediatric masks and more. It is an extremely easy to use nebulizer which can be operated with a single button. The product comes with an 18-month warranty which provides the user with added peace of mind about his or her purchase.

Special Features:

  • Versatile Usage
  • Complete Mask Set
  • 18 Months Warranty
  • Single Button Operation
  • Recommended Uses
Pros
Cons
Easy Operation No Detailed Technical Specifications
Low Noise
Complete Mask Set

Buy Now: OTICA Nebulizer Machine for Adult and Kids

9. Control D NEB112 Respiratory Nebulizer


A portable and handy option, Control D NEB112 Respiratory Nebulizer is our next suggestion on the list. It features a highly sophisticated motor to atomize the medication into fine particles which results in effective delivery of the medication to the respiratory tract. It is designed to target adults and children alike providing effective medication delivery to all age groups. It is also designed for easy cleaning which ensures hygiene and maintenance resulting in better treatment results.

Special Features:

  • Effective Nebulization
  • Portable and Handy
  • Multiple Inhalation Options
  • Efficient Respiratory Therapy
  • Easy Carry Handle
  • Complete Nebulizer Kit
  • Easy to Clean
  • Ideal for All Ages
Pros
Cons
Portable and Lightweight No Detailed Technical Specifications
Complete Nebulizer Kit
Easy to Use and Clean

Buy Now: Control D NEB112 Respiratory Nebulizer

10. Dr Trust Plastic Bestest Compressor Nebuliser Machine Kit


Our next suggestion for this article is the Dr Trust Plastic Bestest Compressor Nebulizer Machine Kit which features flow adjuster and RespiRight technology. The first features allow the user to control the airflow for personalised comfort that falls between 0.5-5 ml/min making it perfect for adults and kids. The later feature ensures inhalation of respiratory medication is effective and thorough which ensures maximum adsorption into the lungs. In addition to this, it ensures low noise operation, comprehensive kit, user friendliness and portability.

Special Features:

  • Flow Adjuster
  • RespiRight Technology
  • Compatible with Various Medications
  • Low Noise Operation
  • Two Masks & Mouthpiece
  • Simple to Use
  • Handy and Portable
  • Average Nebulization Rate
Pros
Cons
Flow Adjustability No Detailed Technical Specifications
Low Noise Operation
RespiRight Technology

Buy Now: Dr Trust Plastic Bestest Compressor Nebulizer Machine Kit

Similar Products for You:

Omron Nebulizer Microair NE-U100 Portable Pocket Sized 360 Degree Silent Mesh Nebulizer (White)

AmbiTech Easy Nebulizer Machine With 2 Year Replacement Warranty For Adults & Kids

K-Life Neb-101 Compressor Nebulizer Machine Kit with Child and Adult Masks (Brown) (2 YEAR WARRANTY)

Control D Blue & White Compressor Complete Kit Nebulizer with Child and Adult Masks

Control D White Compressor Complete Kit Nebulizer with Child and Adult Mask Kit

Frequently Asked Questions: Best Nebulizer Machine in India

Q1. What is a nebulizer machine used for?

Ans: Nebulizer is a small machine that is designed to turn liquid medicine into fine mist which is easier for absorption in the lungs. They are used for a variety of health conditions such as COPD, asthma, and cystic fibrosis, and are sometimes used in conjunction with inhalers.

Q2. Is a nebulizer good for your lungs?

Ans: A nebulizer can help you deal with inflammation in your lungs and open airways. It is highly effective in the case of respiratory illnesses like asthma, COPD who have lung-related complications from a cold or flu.

Q3. Is nebulization good for coughing?

Ans: Yes, you can turn to Nebulization in case of cough as this process is highly effective when it comes to lung illnesses. This machine allows you to inhale steroids which can calm the inflammation in your mucous membrane which will enable your body to begin to heal. This treatment can drastically reduce symptoms and illnesses including coughing, sputum production, and chest tightness, allowing you to breathe easier.

Disclaimer : The above content is non-editorial and produced by a third party advertiser. Times Internet Limited/ Economic Times does not guarantee, vouch for or endorse any of the content or its genuineness. The product prices mentioned in the article are subject to change including depending upon offers given by Amazon.

Source link

(MENAFN- IMARC Group)
According to IMARC Group latest report titled“ Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032 ”, offers a comprehensive analysis of the industry, which comprises insights on oxygen therapy market demand . The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global oxygen therapy market size reached US$ 18.9 Billion in 2023 . Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032 , exhibiting a growth rate (CAGR) of 6.4% during 2024-2032.

Request a Free Sample Report: /oxygen-therapy-market/requestsample

Oxygen therapy is a medical intervention that involves administering supplemental oxygen to individuals with respiratory conditions or low blood oxygen levels. It is a crucial medical treatment for various conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, and respiratory distress. The primary goal of oxygen therapy is to ensure an adequate supply of oxygen to the body's tissues and organs, improving overall oxygen saturation levels in the blood. This therapy is delivered through various devices, including nasal cannulas, face masks, or ventilators, depending on the severity of the respiratory impairment. Oxygen therapy helps alleviate symptoms such as shortness of breath, fatigue, and confusion, enhancing the patient's overall well-being and supporting the body's healing process. Proper monitoring and adjustment of oxygen levels are essential to optimize its effectiveness while minimizing the risk of complications.

Market Trends:

The global market is majorly driven by the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and pneumonia. As the elderly population increases, so does the incidence of respiratory conditions, necessitating the use of oxygen therapy to manage and improve patients' respiratory function. Besides, advancements in technology have led to the development of innovative and more efficient oxygen delivery devices, enhancing patient comfort and compliance. Portable oxygen concentrators, for instance, have gained popularity, allowing individuals greater mobility and flexibility in their daily activities. Moreover, the growing awareness and understanding of the benefits of oxygen therapy among healthcare professionals and patients contribute to increased adoption. The therapy's efficacy in alleviating symptoms, improving quality of life, and supporting overall health drive its acceptance in diverse medical settings. Additionally, the ongoing COVID-19 pandemic has heightened the demand for oxygen therapy as respiratory support for severely affected patients. Furthermore, the expanding home healthcare sector and the preference for non-invasive respiratory interventions foster market growth, as more patients opt for in-home oxygen therapy solutions.

Competitive Landscape

  • Allied Healthcare Products Inc.

  • Becton Dickinson and Company

  • DeVilbiss Healthcare LLC (Drive Medical Inc.)

  • Fisher & Paykel Healthcare Limited

  • General Electric Company

  • Getinge AB

  • Hersill SL

  • Invacare Corporation

  • Koninklijke Philips N.V

  • Smiths Group plc

  • Tecno-Gaz S.p.A.

  • Teleflex Incorporated

Key Market Segmentation:

Our report has categorized the market based on region, product,
application and end use.

Breakup by Product:

  • Oxygen Source Equipment

  • Oxygen Delivery Devices

Breakup by Application:

  • Chronic Obstructive Pulmonary Disease

  • Asthma

  • Obstructive Sleep Apnea

  • Respiratory Distress Syndrome

  • Cystic Fibrosis

  • Pneumonia

  • Others

Breakup by End Use:

  • Home Healthcare

  • Hospitals

Breakup by Region:

  • North America (United States, Canada)

  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

  • Asia Pacific (China, Japan, India, Australia, Indonesia, South Korea, Others)

  • Latin America (Brazil, Mexico, Others)

  • Middle East and Africa

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: --

Tel No:(D) +91 120 433 0800

United States: +1–631–791–1145 | United Kingdom: +44–753–713–2163

MENAFN07022024004122016232ID1107822474


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Source link